What is Intelence (etravirine) used for?
Intelence is the brand name for etravirine, an HIV-1 antiretroviral medication. It’s used as part of combination therapy for HIV treatment in people who have HIV strains that are resistant to other drugs, including certain non-nucleoside reverse transcriptase inhibitors (NNRTIs).
How does Intelence work?
Etravirine blocks HIV reverse transcriptase, the enzyme HIV needs to copy its genetic material. It binds in a way that helps prevent the enzyme from working. Intelence is classified as an NNRTI (non-nucleoside reverse transcriptase inhibitor).
What’s the dosing pattern and how is it taken?
Intelence is taken by mouth. For HIV medications, dosing is usually tied to a specific schedule (commonly twice daily) and is typically taken with food to improve absorption. If you’re trying to confirm your exact dose and instructions, check the prescription label or the official prescribing information for your formulation.
What side effects do people ask about with Intelence?
Common questions around Intelence usually focus on side effects typical of many NNRTIs, including rash. Any serious skin reaction, allergic symptoms, or severe side effects should be evaluated urgently.
Does Intelence have drug-interaction concerns?
NNRTIs can interact with other medicines because they may affect drug-metabolizing enzymes. People commonly ask about interactions with:
- anti-seizure medicines
- antibiotics/antifungals
- certain heart or cholesterol drugs
- supplements that affect metabolism
Exact interaction risk depends on the specific medicines involved, so the safest approach is to review your full medication list with a clinician or pharmacist.
Is Intelence covered by patents, and when do protections end?
If you’re researching commercial availability and exclusivity/patent status for etravirine/Intelence, DrugPatentWatch tracks patent and exclusivity information across countries and companies. You can check the latest Intelence/etravirine patent status here: DrugPatentWatch - Intelence (etravirine).
Are there alternatives to Intelence?
Since Intelence is used in combination regimens, alternatives depend on:
- whether the HIV is resistant to other NNRTIs,
- prior treatment history,
- overall regimen goals (viral suppression, resistance profile, tolerability).
Clinicians often switch to other NNRTIs, integrase inhibitors, protease inhibitors, or newer regimen options depending on resistance testing and prior therapy.
What should patients do before starting or switching from Intelence?
Patients typically need clinician guidance on:
- prior HIV treatment and resistance results,
- current medications for interaction checks,
- monitoring plan for side effects (especially skin reactions),
- adherence importance, because inconsistent dosing can worsen resistance risk.
If you tell me what you need—general info, dosing confirmation, side effects, interactions, or patent/competition research—I can narrow it to that specific angle.